Evidence Hub

Quantum-Sized Sb@Au Schottky Heterostructure for Sensitized Radioimmunotherapy

Shen C, Niu X, Chen J, Xu F, Liu M, Duan Y, Du H, Shang Q et al.

Nano letters, 2025

Abstract

Radiodynamic therapy (RDT) holds great potential for overcoming radioresistance and enhancing tumor immunogenicity. However, its efficacy is hindered by limited reactive oxygen species (ROS) generation due to insufficient carrier generation and transfer, which often results in tumor metastasis. Here, we report quantum-sized and narrow-bandgap Sb@Au Schottky heterostructures, namely, Sb@Au nanodots (Sb@Au NDs), to improve ROS generation for sensitizing RDT and inhibiting tumor metastasis. Experimental results and density functional theory calculations show that Sb@Au NDs give narrow bandgap and high Schottky potential barrier for promoting carrier generation and separation under X-ray irradiation, and present rich active sites for improving catalytic performance, leading to abundant ROS generation and significantly amplifying intracellular oxidative stress to enhance RDT. Sb@Au ND-sensitized RDT greatly induces immunogenic cell death and thus promotes CD8+ T cell-mediated systemic immunity, ultimately suppressing tumor metastasis. Our finding highlights the potential of narrow-bandgap Sb@Au NDs as an effective sensitizer for radioimmunotherapy.

How strong is the evidence?

Evidence Hub reads this as a experimental / empirical study, done in animal and cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free